Skip to content

Clinical trials

Phase 3 Polycythemia Vera trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycythemia Vera Phase: Phase 3 Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20051
20071
20082
20101
20111
20121
20131
20141
20222
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting3
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology2
CTI BioPharma2
Incyte Corporation2
Memorial Sloan Kettering Cancer Center2
Protagonist Therapeutics, Inc.2
Case Comprehensive Cancer Center1
INSYS Therapeutics Inc1
Italfarmaco1
Merck Sharp & Dohme LLC1
Ono Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycythemia Vera18
Thrombocythemia, Essential12
Primary Myelofibrosis10
Myeloproliferative Disorders8
Blast Crisis7
Burkitt Lymphoma7
Hodgkin Disease7
Immunoblastic Lymphadenopathy7
Immunoglobulin Light-chain Amyloidosis7
Intraocular Lymphoma7

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.